Trial Profile
A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs CJ 30044 (Primary) ; Bepotastine
- Indications Allergic conjunctivitis; Allergic rhinitis; Perennial allergic rhinitis; Pruritus; Seasonal allergic rhinitis; Urticaria
- Focus Pharmacokinetics
- Sponsors HK inno.N
- 21 Aug 2013 New trial record